The in vitro element demonstrated that each glucagon and Retatrutide immediately lowered ANGPTL3/8 secretion from hepatocytes, and this effect was blocked by a glucagon receptor (GCGR) antagonist. These findings suggest which the GCGR agonism of Retatrutide contributes into the reduction in circulating ANGPTL3/eight, which consequently may possibly